Back

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease Prevention and Treatment: What Drives Change? Public Health ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Inna Thalmann

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom
Doctor E. Sidelnkov (Rotkreuz, CH)
Abstract Slides Video
Presentation thumbnail
Management of conflicts of interests of ESC guideline authors
Professor H. Seggewiss (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Burnout in residency: are cardiology residents more affected?
Mr A. Sigal (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
The assessment of the accuracy and credibility of cardiovascular health information on social media platforms
Doctor A. Ragab (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular Disease Prevention and Treatment: What Drives Change?

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Presentation
The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia
thumbnail
Congress Presentation
EHRs and Omics for disease phenotypin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources